Page 3 of salaried individuals

loan, personal loan, salaried individuals, secured loan, home loan, car loan, unsecured loan, personal loan, loan against credit card, regular income, credit score, job stability, EMI, banks, NBFCs

Why are salaried employees more likely to qualify for instant personal loans?

Without any assets kept as security, banks and non banking financial companies (NBFCs) ensure that borrowers have the capacity to…

April 27, 2022 00:05 IST

FM Budget 2022 speech, salaried individuals, taxpayers, income tax, deductions, tax benefits, proposals, budget 2022 expectations, budget 2022-23 expectations, union budget 2022 expectations,

What is in store for salaried individuals in the FM’s Budget 2022 speech

The salaried class has gone through several challenges in the past two years and the amounts expended towards healthcare, child…

Updated: February 1, 2022 09:43 IST

Related News

Asia Cup Trophy Controversy: India refuses award, PCB proposes special handover

Asia Cup 2025 Trophy row: PCB chief Mohsin Naqvi sends firm message to BCCI, says ‘If you want the trophy, we…’

Four big companies have now stopped sponsoring H-1B visas. Here is the full list

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar card update new rules from November 2025: You won’t need to upload documents anymore — here’s how to change your details online

Inside Kangana Ranaut’s opulent Delhi home and her vibrant Diwali celebrations: ‘Interiors better than Kapoors-Khans,’ say netizens

Jefferies buy recommendations, Jefferies stock picks India

3 ‘Buy’ recommendations by Jefferies, with up to 34% upside potential

Dr Reddy’s Q2 FY26 profit rises 6% YoY to Rs 1,426 crore; revenue up 9%

Business45 min ago

Dr Reddy’s Laboratories, a leading pharmaceutical company, saw a 6.36% increase in YoY profit and an 8.9% growth in revenue in the second quarter of FY2025-26. The company’s net profit stood at Rs 1,426 crore, up from Rs 1,341 crore in the previous fiscal year. However, there was a decline in EBITDA and gross margin. While the company’s Europe business saw a significant growth, its North

View all shorts